Nordazepam
- Product NameNordazepam
- CAS1088-11-5
- CBNumberCB2292432
- MFC15H11ClN2O
- MW270.71
- EINECS214-123-4
- MDL NumberMFCD00063440
- MOL File1088-11-5.mol
- MSDS FileSDS
Chemical Properties
| Melting point | 208-210°C |
| Boiling point | 453.1±45.0 °C(Predicted) |
| Density | 1.2576 (rough estimate) |
| refractive index | 1.6330 (estimate) |
| Flash point | 11 °C |
| storage temp. | 2-8°C |
| solubility | DMSO: >10mg/mL |
| pka | pKa 3.5 12.0 (5%MeOH in H2O t=20 I=0.15) (Uncertain) |
| form | neat &_& powder |
| color | white to light tan |
| Major Application | clinical testing |
| InChI | 1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19) |
| InChIKey | AKPLHCDWDRPJGD-UHFFFAOYSA-N |
| SMILES | Clc1ccc2NC(=O)CN=C(c3ccccc3)c2c1 |
| LogP | 2.930 |
| EWG's Food Scores | 1 |
| FDA UNII | 67220MCM01 |
| ATC code | N05BA16 |
Safety
| Symbol(GHS) |
|
|||||||||
| Signal word | Warning | |||||||||
| Hazard statements | H302 | |||||||||
| Precautionary statements | P264-P270-P301+P312-P501 | |||||||||
| Hazard Codes | Xn,T,F | |||||||||
| Risk Statements | 22-39/23/24/25-23/24/25-11 | |||||||||
| Safety Statements | 7-16-36/37-45 | |||||||||
| RIDADR | 3249 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | DF1750000 | |||||||||
| HazardClass | 6.1(b) | |||||||||
| PackingGroup | III | |||||||||
| HS Code | 2933910000 | |||||||||
| Storage Class | 3 - Flammable liquids | |||||||||
| Hazard Classifications | Acute Tox. 3 Dermal Acute Tox. 3 Inhalation Acute Tox. 3 Oral Flam. Liq. 2 STOT SE 1 | |||||||||
| Toxicity | LD50 in mice (mg/kg): 2750 orally, >400 i.p. (Randall); LD50 in mice, rats (mg/kg): 1300, >5200 orally (company communication) | |||||||||
| NFPA 704: |
|